ÃÛÌÒÊÓÆµ

Private Equity

  • September 25, 2025

    Second 'Drugs Made In America' SPAC Raises $500M In IPO

    Drugs Made In America Acquisition II, a special purpose acquisition company planning to target companies in the pharmaceutical industry, began trading publicly on Thursday after pricing a $500 million initial public offering, marking the largest SPAC listing of 2025.

  • September 25, 2025

    Kirkland-Led Ridgemont Secures Nearly $4B For 5th Fund

    Kirkland & Ellis LLP-advised private equity shop Ridgemont Equity Partners on Thursday revealed that it wrapped fundraising on its fifth fund after receiving $3.975 billion of investor commitments.

  • September 25, 2025

    Oakley Capital Launches Euro Insurance Services Platform

    Private equity company Oakley Capital said Thursday it has launched an insurance services platform to consolidate companies in southern Europe.

  • September 25, 2025

    TA Associates Affiliate Trims Stake In Eurowag, Raises £56M

    An affiliate of private equity firm TA Associates Management LP has sold part of its stake in European payments provider Eurowag for approximately £56.1 million ($75.3 million), its bookrunner Peel Hunt LLP said Thursday.

  • September 25, 2025

    Freshfields, Fried Frank-Led Petershill To Exit London Listing

    Goldman Sachs-owned private equity investor Petershill Partners PLC said on Thursday that it is planning to leave the London Stock Exchange and return up to $932 million of capital to shareholders to enhance its value, in a new blow to the bourse.

  • September 25, 2025

    Milbank Advises AI Biz Nscale On $1.1B Series B Funding

    British AI infrastructure operator Nscale said Thursday that it has raised $1.1 billion from investors, including tech giant Nvidia, to expand its data centers.

  • September 24, 2025

    Skechers Investor Seeks Chancery Appraisal Of $9.4B Deal

    A Skechers shareholder is asking the Delaware Chancery Court for an appraisal to determine the fairness of the $63-per-share buyout price of nearly 700,000 shares in the footwear company after its $9.4 billion take-private deal with 3G Capital.

  • September 24, 2025

    Defunct Tech Co.'s CEO Bilked Investors Of $120M, Feds Say

    The founder of a defunct Canadian technology company faces criminal charges and a civil suit in California federal court by securities regulators on Wednesday stemming from a fraud scheme where he allegedly raised $120 million after providing investors with bogus financial statements that inflated the company's financial condition and performance.

  • September 24, 2025

    Kirkland, Willkie Steer IAS' $1.9B 'AI-First' Sale To Novacap

    Integral Ad Science, a global digital media measurement and optimization company, said Wednesday that it has agreed to be acquired by private equity firm Novacap in an all-cash transaction valued at about $1.9 billion, with Kirkland & Ellis LLP advising IAS and Willkie Farr & Gallagher LLP guiding Novacap.

  • September 24, 2025

    FTC Merger Filing Overhaul Is Clear Overstep, Chamber Says

    The U.S. Chamber of Commerce and other groups challenging the Federal Trade Commission's recent overhaul of its premerger reporting requirements told a Texas federal court the changes create an unnecessary burden for thousands of deals that raise no competition concerns.

  • September 24, 2025

    Merrill Lynch Accuses Ex-Staff, Schwab, Investor Of IP Theft

    Merrill Lynch has filed a trade secrets lawsuit against a dozen former employees, Charles Schwab and Dynasty Financial Partners, alleging the defendants conspired to start a new independent financial advisory firm with Merrill's staff and confidential information.

  • September 24, 2025

    Del. Justices Uphold $10.5B Zendesk Take-Private Deal

    Delaware's Supreme Court early Wednesday upheld the Court of Chancery's Sept. 10 dismissal of a stockholder challenge to the $10.5 billion take-private deal for software as a service business Zendesk Inc., closing the book on the case in two sentences issued two weeks after appeal arguments.

  • September 24, 2025

    Olo Investor Sues For Records On $2B Thoma Bravo Deal

    A hedge fund has filed a books and records demand against a restaurant software company in Delaware Chancery Court, hoping to investigate whether the stock price in its $2 billion merger with Thoma Bravo was fair and threatening a potential appraisal action.

  • September 24, 2025

    Kirkland, Davis Polk Lead Mirion's $585M Paragon Buy

    Radiation detection company Mirion, advised by Davis Polk & Wardwell LLP, on Wednedsay announced that it has agreed to buy Kirkland & Ellis LLP-led nuclear power company Paragon Energy Solutions from private equity shop Windjammer Capital in a $585 million cash deal.

  • September 24, 2025

    Loeb & Loeb, Kirkland Guide SPAC Lafayette's $250M IPO

    Guided by Loeb & Loeb LLP and underwriters' counsel Kirkland & Ellis LLP, special purpose acquisition company Lafayette Digital Acquisition I filed Tuesday for a $250 million initial public offering with the U.S. Securities and Exchange Commission with hopes to acquire blockchain- or fintech-related merger targets.

  • September 24, 2025

    Battery Ventures Leads $165M Investment In Risk AI Biz

    Wilson Sonsini Goodrich & Rosati PC-advised risk intelligence platform Signal AI on Wednesday announced that technology-focused investment firm Battery Ventures led a $165 million investment round, resulting in the firm taking a majority stake in the London-headquartered tech company.

  • September 24, 2025

    PE-Focused Debt Finance Pro Boosts Cooley's Boston Office

    Cooley LLP has grown its debt finance practice in Boston with the addition of a Choate Hall & Stewart LLP attorney.

  • September 23, 2025

    RadioShack Reboot Plan Morphed Into $112M Scam, SEC Says

    The U.S. Securities and Exchange Commission sued three former Retail Ecommerce Ventures LLC executives in Florida federal court Tuesday, alleging they raised $112 million through fraudulent securities offerings that operated as a Ponzi-like scheme that promised bogus 25% annual returns to revitalize popular REV brands including RadioShack and Pier 1 Imports.

  • September 23, 2025

    Hedge Funds Call For CFTC To End Dual Registration

    A group representing the hedge fund industry is calling on the U.S. Commodity Futures Trading Commission to drop the need for industry participants to submit to agency oversight in cases where fund managers are already registered with the U.S. Securities and Exchange Commission, calling the dual registration requirement "costly" and "inefficient."

  • September 23, 2025

    How Attys Are Riding The Mass. Biotech 'Roller Coaster'

    The first half of 2025 saw the Massachusetts biotech industry post bleak numbers, including a dip in venture capital funding and merger activity, leaving attorneys looking for creative ways to help companies with fewer public and private dollars.

  • September 23, 2025

    Cantor Fitzgerald, Citibank Hit With Trading Patent Suits

    Several financial services businesses, including Citibank and Secretary of Commerce Howard Lutnick's former firm Cantor Fitzgerald, have been sued in New York and Texas federal court over their alleged infringement of a trading patent.

  • September 23, 2025

    Climate Transition-Focused SPAC Plans For $150M IPO

    Special purpose acquisition company Climate Transition Special Opportunities SPAC I has filed plans with U.S. regulators to raise up to $150 million in its initial public offering, with the goal of acquiring a company in the renewable energy or specialty finance space.

  • September 23, 2025

    Sullivan & Cromwell Guides Sempra On $10B Subsidiary Sale

    Sempra said Tuesday it has agreed to sell a 45% stake in its infrastructure subsidiary to a consortium led by KKR and Canada's CPP Investments for $10 billion, while separately securing $7 billion of equity financing led by Blackstone to advance a major liquefied natural gas project in Texas.

  • September 23, 2025

    AI Health Benefits Platform Secures $400M In New Funding

    Enterprise health technology company Capital Rx Inc. announced Tuesday that it has secured a $400 million investment and will subsequently rebrand as Judi Health to "better reflect its roots" as a full-service health benefits technology company.

  • September 22, 2025

    Oracle To Secure TikTok Users' Data In Deal To Skirt US Ban

    Tech giant Oracle will be tasked with safeguarding U.S. TikTok users' personal data, and the app's recommendation algorithm will be "retrained" and operated outside the control of TikTok's Chinese parent company under a deal that President Donald Trump is expected to sign this week to avert a shutdown of TikTok, the White House said Monday. 

Expert Analysis

  • SEC Rulemaking Radar: The Debut Of Atkins' 'New Day'

    Author Photo

    The U.S. Securities and Exchange Commission's regulatory flex agenda, published last week, demonstrates a clear return to appropriately tailored and mission-focused rulemaking, with potential new rules applicable to brokers, exchanges and trading, among others, say attorneys at Goodwin.

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • What To Expect As Trump's 401(k) Order Materializes

    Author Photo

    Following the Trump administration’s recent executive order on 401(k) plan investments in alternative assets like cryptocurrencies and real estate, the U.S. Department of Labor and the U.S. Securities and Exchange Commission will need to answer several outstanding questions before any regulatory changes are implemented, say attorneys at Cleary.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • With Obligor Ruling, Ohio Justices Calm Lending Waters

    Author Photo

    A recent decision by the Ohio Supreme Court, affirming a fundamental principle that lenders have no duty to disclose material risks to obligors, provides clarity for commercial lending practices in Ohio and beyond, and offers a reminder of the risks presented by guarantee arrangements, says Carrie Brosius at Vorys.

  • Evaluating The SEC's Rising Whistleblower Denial Rate

    Author Photo

    The rising trend of U.S. Securities and Exchange Commission whistleblower award claim denials represents a departure from the SEC's previous track record and may reflect a more conservative approach to whistleblower award determinations under the current administration, say attorneys at Troutman Pepper.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Unpacking The New Opportunity Zone Tax Incentive Program

    Author Photo

    The One Big Beautiful Bill Act brought several improvements to the opportunity zone tax incentive program that should boost investments in qualified funds, including making it permanent, increasing federal income tax benefits in rural areas, redesignating the qualified zones, and requiring more in-depth reporting, says Marc Schultz at Snell & Wilmer.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • Navigating Brazil's Regulations, Incentives For Green Projects

    Author Photo

    Brazil's evolving environmental regulatory framework and ongoing moves to attract international capital for climate-focused projects may appeal to U.S.-based companies and investors interested in sustainable development — but taking advantage of these opportunities requires careful planning and meaningful stakeholder engagement, says Milena Angulo at Guimarães.

  • Texas Property Law Complicates Financing And Development

    Author Photo

    A new Texas law imposing expansive state-level restrictions on properties owned by entities from designated countries creates a major obstacle for some lenders, developers and other stakeholders, as well as new diligence requirements for foreign companies, say attorneys at Pillsbury.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.